Top Markets
#1 Black Phoenix Black Phoenix +827.96%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +26.72%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.63%
#4 pipedog pipedog +22.83%
#5 Bless Bless +22.61%
#6 SAFEcoin SAFEcoin +21.43%
#7 Beam Beam +20.30%
#8 Magma Finance Magma Finance +19.26%
#9 PondCoin PondCoin +18.61%
#10 YFSX YFSX +16.00%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Zymeworks Inc. Zymeworks Inc.

Zymeworks Inc.

ZYME
Classifica tra le azioni #6233
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase,... Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alliances with several pharmaceutical leaders, including Merck Sharp & Dohme Research Ltd., Eli Lilly and Company, Bristol-Myers Squibb company, GlaxoSmithKline Intellectual Property Development Ltd., Daiichi Sankyo Co., Ltd., Janssen Biotech, Inc., BeiGene, Ltd., and Exelixis, Inc. Furthermore, it engages in cooperative research and licensing agreements with LEO Pharma A/S, specifically for the exploration, advancement, and market introduction of bispecific antibodies, and with Iconic Therapeutics, Inc. Established in 2003, Zymeworks Inc. operates from its headquarters located in Vancouver, Canada.
Prezzo delle azioni
$29.33
Capitalizzazione di mercato
$2.16B
Variazione (1 giorno)
0.07%
Variazione (1 anno)
96.42%
Paese
US
Scambia Zymeworks Inc. (ZYME)

Categoria

Healthcare
Storico del prezzo dell'azione per Zymeworks Inc. (ZYME)
Prezzo di chiusura più alto: $26.22 il 2026-08-01

Prezzo di chiusura più basso: $13.00 il 2017-04-01
Storico del prezzo dell'azione di Zymeworks Inc. dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -12.16%
2025 90.41%
2024 44.87%
2023 30.92%
2022 -56.92%
2021 -67.45%
2020 19.67%
2019 233.57%
2018 63.85%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.48 40.97%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.38%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.50 459.76%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH